Cargando…
Retracted: Elevated Plasma Interleukin-35 as a Prognostic Indicator in Localized Clear Cell Renal Cell Carcinoma
Autor principal: | and Alternative Medicine, Evidence-Based Complementary |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Hindawi
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10307213/ https://www.ncbi.nlm.nih.gov/pubmed/37387965 http://dx.doi.org/10.1155/2023/9846548 |
Ejemplares similares
-
Retracted: A Novel Biomarker, FKBP10, for Poor Prognosis Prediction in Patients with Clear Cell Renal Cell Carcinoma
por: and Alternative Medicine, Evidence-Based Complementary
Publicado: (2023) -
Retracted: NEK2 Serves as a Novel Biomarker and Enhances the Tumorigenicity of Clear-CellRenal-Cell Carcinoma by Activating WNT/β-Catenin Pathway
por: and Alternative Medicine, Evidence-Based Complementary
Publicado: (2023) -
Retracted: Clinical Significance of Peripheral Blood Th1 and Th17 Cell Content and Serum IL-35 and IL-17 Expression in Patients with Ankylosing Spondylitis
por: and Alternative Medicine, Evidence-Based Complementary
Publicado: (2023) -
Retracted: Prognostic Evaluation of Vitrectomy Assisted by Lucentis in Diabetic Retinopathy and Neovascular Glaucoma
por: and Alternative Medicine, Evidence-Based Complementary
Publicado: (2023) -
Retracted: An Immune-Related Prognostic Risk Model in Colon Cancer by Bioinformatics Analysis
por: and Alternative Medicine, Evidence-Based Complementary
Publicado: (2023)